| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|
| chlormethiazole | [no description available] | medium | 2 | 2 | thiazoles | |
| clobazam | [no description available] | medium | 5 | 0 | 1,4-benzodiazepinone;
organochlorine compound | anticonvulsant;
anxiolytic drug;
GABA modulator |
| fluoxetine | [no description available] | medium | 2 | 0 | (trifluoromethyl)benzenes;
aromatic ether;
secondary amino compound | |
| bromazepam | [no description available] | medium | 4 | 1 | organic molecular entity | |
| amphetamine | [no description available] | medium | 2 | 0 | primary amine | |
| diazepam | [no description available] | medium | 97 | 31 | 1,4-benzodiazepinone;
organochlorine compound | anticonvulsant;
anxiolytic drug;
environmental contaminant;
sedative;
xenobiotic |
| buprenorphine | [no description available] | medium | 6 | 0 | morphinane alkaloid | delta-opioid receptor antagonist;
kappa-opioid receptor antagonist;
mu-opioid receptor agonist;
opioid analgesic |
| clomipramine | [no description available] | medium | 5 | 0 | dibenzoazepine | anticoronaviral agent;
antidepressant;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
serotonergic antagonist;
serotonergic drug;
serotonin uptake inhibitor |
| cocaine | [no description available] | medium | 3 | 0 | benzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid | adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic |
| duloxetine hydrochloride | [no description available] | medium | 1 | 0 | duloxetine hydrochloride | antidepressant |
| quetiapine fumarate | [no description available] | medium | 1 | 0 | fumarate salt | |
| topiramate | [no description available] | medium | 1 | 0 | cyclic ketal;
ketohexose derivative;
sulfamate ester | anticonvulsant;
sodium channel blocker |
| D-fructopyranose | [no description available] | medium | 1 | 0 | cyclic hemiketal;
D-fructose;
fructopyranose | sweetening agent |
| clonazepam | [no description available] | medium | 10 | 0 | 1,4-benzodiazepinone;
monochlorobenzenes | anticonvulsant;
anxiolytic drug;
GABA modulator |
| flunitrazepam | [no description available] | medium | 12 | 3 | 1,4-benzodiazepinone;
C-nitro compound;
monofluorobenzenes | anxiolytic drug;
GABAA receptor agonist;
sedative |
| methadone | [no description available] | medium | 3 | 1 | benzenes;
diarylmethane;
ketone;
tertiary amino compound | |
| benactyzine | [no description available] | medium | 1 | 1 | diarylmethane | |
| metamizil | [no description available] | medium | 1 | 1 | | |
| lidocaine | [no description available] | medium | 3 | 1 | benzenes;
monocarboxylic acid amide;
tertiary amino compound | anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic |
| mexazolam | [no description available] | medium | 1 | 0 | hemiaminal ether;
oxazolobenzodiazepine | |
| amitriptyline | [no description available] | medium | 6 | 0 | carbotricyclic compound;
tertiary amine | adrenergic uptake inhibitor;
antidepressant;
environmental contaminant;
tropomyosin-related kinase B receptor agonist;
xenobiotic |
| carbamazepine | [no description available] | medium | 5 | 0 | dibenzoazepine;
ureas | analgesic;
anticonvulsant;
antimanic drug;
drug allergen;
EC 3.5.1.98 (histone deacetylase) inhibitor;
environmental contaminant;
glutamate transporter activator;
mitogen;
non-narcotic analgesic;
sodium channel blocker;
xenobiotic |
| alfuzosin | [no description available] | medium | 1 | 0 | monocarboxylic acid amide;
quinazolines;
tetrahydrofuranol | alpha-adrenergic antagonist;
antihypertensive agent;
antineoplastic agent |
| quinazolines | [no description available] | medium | 2 | 0 | azaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinazolines | |
| meprobamate | [no description available] | medium | 2 | 0 | organic molecular entity | |
| n-desmethylclobazam | [no description available] | medium | 1 | 0 | benzodiazepine | |
| paroxetine | [no description available] | medium | 1 | 0 | aromatic ether;
benzodioxoles;
organofluorine compound;
piperidines | antidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor |
| quinoxalines | [no description available] | medium | 1 | 0 | mancude organic heterobicyclic parent;
naphthyridine;
ortho-fused heteroarene | |
| cyamemazine | [no description available] | medium | 1 | 0 | phenothiazines | |
| haloperidol | [no description available] | medium | 5 | 0 | aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol | antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist |
| midazolam | [no description available] | medium | 6 | 3 | imidazobenzodiazepine;
monofluorobenzenes;
organochlorine compound | anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative |
| brotizolam | [no description available] | medium | 1 | 0 | organic molecular entity | |
| alprazolam | [no description available] | medium | 5 | 1 | organochlorine compound;
triazolobenzodiazepine | anticonvulsant;
anxiolytic drug;
GABA agonist;
muscle relaxant;
sedative;
xenobiotic |
| s 22153 | [no description available] | medium | 1 | 0 | | |
| s20098 | [no description available] | medium | 1 | 0 | acetamides | |
| melatonin | [no description available] | medium | 1 | 0 | acetamides;
tryptamines | anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger |
| sb 243213 | [no description available] | medium | 1 | 0 | indolyl carboxylic acid | |
| thiophenes | [no description available] | medium | 1 | 0 | mancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound | non-polar solvent |
| enkephalin, ala(2)-mephe(4)-gly(5)- | [no description available] | medium | 1 | 0 | | |
| venlafaxine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | |
| citalopram | [no description available] | medium | 1 | 0 | 2-benzofurans;
cyclic ether;
nitrile;
organofluorine compound;
tertiary amino compound | |
| cyclohexanol | [no description available] | medium | 1 | 0 | cyclohexanols;
secondary alcohol | solvent |
| flumazenil | [no description available] | medium | 10 | 0 | ethyl ester;
imidazobenzodiazepine;
organofluorine compound | antidote to benzodiazepine poisoning;
GABA antagonist |
| zolpidem | [no description available] | medium | 3 | 1 | imidazopyridine | central nervous system depressant;
GABA agonist;
sedative |
| oxazepam | [no description available] | medium | 22 | 3 | 1,4-benzodiazepinone;
organochlorine compound | anxiolytic drug;
environmental contaminant;
xenobiotic |
| pentylenetetrazole | [no description available] | medium | 5 | 0 | organic heterobicyclic compound;
organonitrogen heterocyclic compound | |
| olanzapine | [no description available] | medium | 1 | 0 | benzodiazepine;
N-arylpiperazine;
N-methylpiperazine | antiemetic;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
serotonin uptake inhibitor |
| methamphetamine | [no description available] | medium | 1 | 0 | amphetamines;
secondary amine | central nervous system stimulant;
environmental contaminant;
neurotoxin;
psychotropic drug;
xenobiotic |
| ro13-9904 | [no description available] | medium | 1 | 0 | | |
| nordazepam | [no description available] | medium | 44 | 11 | 1,4-benzodiazepinone;
organochlorine compound | anticonvulsant;
anxiolytic drug;
GABA modulator;
human metabolite;
sedative |
| lorazepam | [no description available] | medium | 24 | 6 | benzodiazepine | |
| nitrazepam | [no description available] | medium | 8 | 0 | 1,4-benzodiazepinone;
C-nitro compound | anticonvulsant;
antispasmodic drug;
drug metabolite;
GABA modulator;
sedative |
| cloxazolam | [no description available] | medium | 1 | 0 | hemiaminal ether;
oxazolobenzodiazepine | |
| gamma-aminobutyric acid | [no description available] | medium | 5 | 0 | amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid | human metabolite;
neurotransmitter;
Saccharomyces cerevisiae metabolite;
signalling molecule |
| glutamine | [no description available] | medium | 1 | 0 | amino acid zwitterion;
glutamine family amino acid;
glutamine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid | EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite |
| flurazepam | [no description available] | medium | 7 | 1 | 1,4-benzodiazepinone;
monofluorobenzenes;
organochlorine compound;
tertiary amino compound | anticonvulsant;
anxiolytic drug;
GABAA receptor agonist;
sedative |
| halazepam | [no description available] | medium | 3 | 2 | organic molecular entity | |
| nitroglycerin | [no description available] | medium | 1 | 0 | nitroglycerol | explosive;
muscle relaxant;
nitric oxide donor;
prodrug;
tocolytic agent;
vasodilator agent;
xenobiotic |
| aluminum hydroxide, magnesium hydroxide, drug combination | [no description available] | medium | 2 | 2 | | |
| chlordiazepoxide | [no description available] | medium | 19 | 1 | benzodiazepine | |
| phenytoin | [no description available] | medium | 6 | 2 | imidazolidine-2,4-dione | anticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent |
| phenobarbital | [no description available] | medium | 7 | 2 | barbiturates | anticonvulsant;
drug allergen;
excitatory amino acid antagonist;
sedative |
| 2-acetylaminofluorene | [no description available] | medium | 1 | 0 | 2-acetamidofluorenes | antimitotic;
carcinogenic agent;
epitope;
mutagen |
| verapamil | [no description available] | medium | 1 | 1 | aromatic ether;
nitrile;
polyether;
tertiary amino compound | |
| buspirone | [no description available] | medium | 10 | 7 | azaspiro compound;
N-alkylpiperazine;
N-arylpiperazine;
organic heteropolycyclic compound;
piperidones;
pyrimidines | anxiolytic drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
sedative;
serotonergic agonist |
| prazepam | [no description available] | medium | 6 | 2 | benzodiazepine | |
| imipramine | [no description available] | medium | 6 | 0 | dibenzoazepine | adrenergic uptake inhibitor;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
| digoxin | [no description available] | medium | 3 | 0 | cardenolide glycoside;
steroid saponin | anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
epitope |
| propranolol | [no description available] | medium | 3 | 3 | naphthalenes;
propanolamine;
secondary amine | anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic |
| glucose, (beta-d)-isomer | [no description available] | medium | 1 | 0 | D-glucopyranose | epitope;
mouse metabolite |
| nitroblue tetrazolium | [no description available] | medium | 1 | 0 | organic cation | |
| dehydroepiandrosterone | [no description available] | medium | 1 | 0 | 17-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
androstanoid | androgen;
human metabolite;
mouse metabolite |
| androstenedione | [no description available] | medium | 1 | 0 | 17-oxo steroid;
3-oxo-Delta(4) steroid;
androstanoid | androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite |
| perazine | [no description available] | medium | 1 | 0 | N-alkylpiperazine;
N-methylpiperazine;
phenothiazines | dopaminergic antagonist;
phenothiazine antipsychotic drug |
| promethazine | [no description available] | medium | 5 | 2 | phenothiazines;
tertiary amine | anti-allergic agent;
anticoronaviral agent;
antiemetic;
antipruritic drug;
H1-receptor antagonist;
local anaesthetic;
sedative |
| chlorpromazine | [no description available] | medium | 7 | 0 | organochlorine compound;
phenothiazines;
tertiary amine | anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug |
| cimetidine | [no description available] | medium | 3 | 0 | aliphatic sulfide;
guanidines;
imidazoles;
nitrile | adjuvant;
analgesic;
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor |
| oxazolam | [no description available] | medium | 1 | 0 | hemiaminal ether;
organic molecular entity | |
| corticosterone | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone | human metabolite;
mouse metabolite |
| medazepam | [no description available] | medium | 4 | 1 | organic molecular entity | |
| bendroflumethiazide | [no description available] | medium | 1 | 1 | benzothiadiazine;
sulfonamide | antihypertensive agent;
diuretic |
| methyldopa | [no description available] | medium | 1 | 1 | L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid | alpha-adrenergic agonist;
antihypertensive agent;
hapten;
peripheral nervous system drug;
sympatholytic agent |
| bencyclane | [no description available] | medium | 1 | 0 | benzenes | |
| trimeprazine | [no description available] | medium | 1 | 0 | phenothiazines | |
| muscimol | [no description available] | medium | 2 | 0 | alkaloid;
isoxazoles;
primary amino compound | fungal metabolite;
GABA agonist;
oneirogen;
psychotropic drug |
| valproic acid | [no description available] | medium | 6 | 0 | branched-chain fatty acid;
branched-chain saturated fatty acid | anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent |
| antipyrine | [no description available] | medium | 1 | 0 | pyrazolone | antipyretic;
cyclooxygenase 3 inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic |
| lithium | [no description available] | medium | 1 | 0 | alkali metal atom | |
| meperidine | [no description available] | medium | 5 | 1 | ethyl ester;
piperidinecarboxylate ester;
tertiary amino compound | antispasmodic drug;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic |
| furosemide | [no description available] | medium | 1 | 0 | chlorobenzoic acid;
furans;
sulfonamide | environmental contaminant;
loop diuretic;
xenobiotic |
| butylscopolammonium bromide | [no description available] | medium | 1 | 0 | | |
| pyrrolidonecarboxylic acid | [no description available] | medium | 1 | 0 | 5-oxoproline;
L-proline derivative;
non-proteinogenic L-alpha-amino acid | algal metabolite |
| dipyrone | [no description available] | medium | 1 | 0 | organic sodium salt | anti-inflammatory agent;
antipyretic;
antirheumatic drug;
cyclooxygenase 3 inhibitor;
non-narcotic analgesic;
peripheral nervous system drug;
prodrug |
| metoclopramide | [no description available] | medium | 2 | 1 | benzamides;
monochlorobenzenes;
substituted aniline;
tertiary amino compound | antiemetic;
dopaminergic antagonist;
environmental contaminant;
gastrointestinal drug;
xenobiotic |
| phloroglucinol | [no description available] | medium | 1 | 0 | benzenetriol;
phenolic donor | algal metabolite |
| temazepam | [no description available] | medium | 4 | 0 | benzodiazepine | |
| triazolam | [no description available] | medium | 3 | 0 | triazolobenzodiazepine | sedative |
| maprotiline | [no description available] | medium | 2 | 0 | anthracenes | |
| clodronic acid | [no description available] | medium | 1 | 0 | 1,1-bis(phosphonic acid);
one-carbon compound;
organochlorine compound | antineoplastic agent;
bone density conservation agent |
| caffeine | [no description available] | medium | 1 | 0 | purine alkaloid;
trimethylxanthine | adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic |
| picrotoxin | [no description available] | medium | 1 | 0 | | |
| pentobarbital | [no description available] | medium | 3 | 0 | barbiturates | GABAA receptor agonist |
| viloxazine | [no description available] | medium | 1 | 0 | aromatic ether | |
| desipramine | [no description available] | medium | 2 | 0 | dibenzoazepine;
secondary amino compound | adrenergic uptake inhibitor;
alpha-adrenergic antagonist;
antidepressant;
cholinergic antagonist;
drug allergen;
EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
serotonin uptake inhibitor |
| nifedipine | [no description available] | medium | 1 | 0 | C-nitro compound;
dihydropyridine;
methyl ester | calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent |
| atropine | [no description available] | medium | 3 | 2 | | |
| clonidine | [no description available] | medium | 1 | 1 | clonidine;
imidazoline | |
| succinylcholine | [no description available] | medium | 1 | 1 | quaternary ammonium ion;
succinate ester | drug allergen;
muscle relaxant;
neuromuscular agent |
| tiapamil hydrochloride | [no description available] | medium | 1 | 0 | | |
| benzoin | [no description available] | medium | 1 | 0 | benzoins;
secondary alpha-hydroxy ketone | EC 3.1.1.1 (carboxylesterase) inhibitor |
| warfarin | [no description available] | medium | 1 | 0 | benzenes;
hydroxycoumarin;
methyl ketone | |
| moclobemide | [no description available] | medium | 1 | 0 | benzamides;
monochlorobenzenes;
morpholines | antidepressant;
environmental contaminant;
xenobiotic |
| phenyl acetate | [no description available] | medium | 1 | 0 | benzenes;
phenyl acetates | |
| mephenytoin | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione | anticonvulsant |
| gabapentin | [no description available] | medium | 1 | 0 | gamma-amino acid | anticonvulsant;
calcium channel blocker;
environmental contaminant;
xenobiotic |
| felbamate | [no description available] | medium | 1 | 0 | carbamate ester | anticonvulsant;
neuroprotective agent |
| primidone | [no description available] | medium | 5 | 0 | pyrimidone | anticonvulsant;
environmental contaminant;
xenobiotic |
| bromide | [no description available] | medium | 1 | 0 | halide anion;
monoatomic bromine | |
| thyroxine | [no description available] | medium | 1 | 0 | 2-halophenol;
iodophenol;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
thyroxine zwitterion;
thyroxine | antithyroid drug;
human metabolite;
mouse metabolite;
thyroid hormone |
| atracurium | [no description available] | medium | 1 | 0 | diester;
quaternary ammonium ion | muscle relaxant;
nicotinic antagonist |
| s 16924 | [no description available] | medium | 1 | 0 | | |
| clozapine | [no description available] | medium | 1 | 0 | benzodiazepine;
N-arylpiperazine;
N-methylpiperazine;
organochlorine compound | adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
GABA antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
xenobiotic |
| trazodone | [no description available] | medium | 3 | 1 | monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
triazolopyridine | adrenergic antagonist;
antidepressant;
anxiolytic drug;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor |
| chlorzoxazone | [no description available] | medium | 1 | 0 | 1,3-benzoxazoles;
heteroaryl hydroxy compound;
organochlorine compound | muscle relaxant;
sedative |
| morphine | [no description available] | medium | 3 | 1 | morphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound | anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic |
| diltiazem | [no description available] | medium | 1 | 0 | 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | antihypertensive agent;
calcium channel blocker;
vasodilator agent |
| glycerol | [no description available] | medium | 1 | 0 | alditol;
triol | algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent |
| acetaminophen | [no description available] | medium | 2 | 1 | acetamides;
phenols | antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic |
| codeine | [no description available] | medium | 3 | 1 | morphinane alkaloid;
organic heteropentacyclic compound | antitussive;
drug allergen;
environmental contaminant;
opioid analgesic;
opioid receptor agonist;
prodrug;
xenobiotic |
| nortriptyline | [no description available] | medium | 1 | 1 | organic tricyclic compound;
secondary amine | adrenergic uptake inhibitor;
analgesic;
antidepressant;
antineoplastic agent;
apoptosis inducer;
drug metabolite |
| fluphenazine | [no description available] | medium | 1 | 1 | N-alkylpiperazine;
organofluorine compound;
phenothiazines | anticoronaviral agent;
dopaminergic antagonist;
phenothiazine antipsychotic drug |
| tryptophan | [no description available] | medium | 1 | 0 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan | antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite |
| mepivacaine | [no description available] | medium | 1 | 0 | piperidinecarboxamide | drug allergen;
local anaesthetic |
| levodopa | [no description available] | medium | 1 | 1 | amino acid zwitterion;
dopa;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid | allelochemical;
antidyskinesia agent;
antiparkinson drug;
dopaminergic agent;
hapten;
human metabolite;
mouse metabolite;
neurotoxin;
plant growth retardant;
plant metabolite;
prodrug |
| propantheline | [no description available] | medium | 1 | 0 | xanthenes | |
| quinuclidines | [no description available] | medium | 1 | 0 | quinuclidines;
saturated organic heterobicyclic parent | |
| halothane | [no description available] | medium | 1 | 0 | haloalkane;
organobromine compound;
organochlorine compound;
organofluorine compound | inhalation anaesthetic |
| acepromazine | [no description available] | medium | 2 | 1 | aromatic ketone;
methyl ketone;
phenothiazines;
tertiary amino compound | phenothiazine antipsychotic drug |
| methaqualone | [no description available] | medium | 1 | 0 | quinazolines | GABA agonist;
sedative |
| reserpine | [no description available] | medium | 1 | 0 | alkaloid ester;
methyl ester;
yohimban alkaloid | adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic |
| glutethimide | [no description available] | medium | 1 | 0 | piperidines | |
| naltrexone | [no description available] | medium | 1 | 0 | cyclopropanes;
morphinane-like compound;
organic heteropentacyclic compound | antidote to opioid poisoning;
central nervous system depressant;
environmental contaminant;
mu-opioid receptor antagonist;
xenobiotic |
| nalbuphine | [no description available] | medium | 1 | 0 | organic heteropentacyclic compound | mu-opioid receptor antagonist;
opioid analgesic |
| naloxone | [no description available] | medium | 2 | 0 | morphinane alkaloid;
organic heteropentacyclic compound;
tertiary alcohol | antidote to opioid poisoning;
central nervous system depressant;
mu-opioid receptor antagonist |
| amobarbital | [no description available] | medium | 1 | 0 | barbiturates | |
| trimethadione | [no description available] | medium | 1 | 0 | oxazolidinone | anticonvulsant;
geroprotector |
| ethosuximide | [no description available] | medium | 1 | 0 | dicarboximide;
pyrrolidinone | anticonvulsant;
geroprotector;
T-type calcium channel blocker |
| acetazolamide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide;
sulfonamide;
thiadiazoles | anticonvulsant;
diuretic;
EC 4.2.1.1 (carbonic anhydrase) inhibitor |
| lithium carbonate | [no description available] | medium | 1 | 0 | carbonate salt;
lithium salt | antimanic drug |
| fluvoxamine | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes;
5-methoxyvalerophenone O-(2-aminoethyl)oxime | antidepressant;
anxiolytic drug;
serotonin uptake inhibitor |
| methotrimeprazine | [no description available] | medium | 1 | 0 | phenothiazines;
tertiary amine | anticoronaviral agent;
cholinergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
non-narcotic analgesic;
phenothiazine antipsychotic drug;
serotonergic antagonist |
| droperidol | [no description available] | medium | 2 | 2 | aromatic ketone;
benzimidazoles;
organofluorine compound | anaesthesia adjuvant;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic |
| alfentanil | [no description available] | medium | 1 | 1 | monocarboxylic acid amide;
piperidines | central nervous system depressant;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic;
peripheral nervous system drug |
| pirinitramide | [no description available] | medium | 1 | 0 | nitrile | |
| pentazocine | [no description available] | medium | 1 | 0 | benzazocine | |
| baclofen | [no description available] | medium | 1 | 0 | amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid;
monochlorobenzenes;
primary amino compound | central nervous system depressant;
GABA agonist;
muscle relaxant |
| fenbufen | [no description available] | medium | 1 | 0 | 4-oxo monocarboxylic acid;
biphenyls | non-steroidal anti-inflammatory drug |
| bicuculline | [no description available] | medium | 1 | 0 | benzylisoquinoline alkaloid;
isoquinoline alkaloid;
isoquinolines | agrochemical;
central nervous system stimulant;
GABA-gated chloride channel antagonist;
GABAA receptor antagonist;
neurotoxin |
| enoxacin | [no description available] | medium | 1 | 0 | 1,8-naphthyridine derivative;
amino acid;
fluoroquinolone antibiotic;
monocarboxylic acid;
N-arylpiperazine;
quinolone antibiotic | antibacterial drug;
DNA synthesis inhibitor |
| biphenylylacetic acid | [no description available] | medium | 1 | 0 | | |
| omeprazole | [no description available] | medium | 1 | 1 | aromatic ether;
benzimidazoles;
pyridines;
sulfoxide | |
| bentazepam | [no description available] | medium | 1 | 0 | organonitrogen heterocyclic compound;
organosulfur heterocyclic compound | |
| diphenhydramine | [no description available] | medium | 1 | 1 | ether;
tertiary amino compound | anti-allergic agent;
antidyskinesia agent;
antiemetic;
antiparkinson drug;
antipruritic drug;
antitussive;
H1-receptor antagonist;
local anaesthetic;
muscarinic antagonist;
oneirogen;
sedative |
| cosyntropin | [no description available] | medium | 1 | 1 | | |
| bromhexine | [no description available] | medium | 1 | 0 | organobromine compound;
substituted aniline;
tertiary amino compound | mucolytic |
| theophylline | [no description available] | medium | 1 | 0 | dimethylxanthine | adenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent |
| ambroxol | [no description available] | medium | 1 | 0 | aromatic amine | |
| norfenfluramine | [no description available] | medium | 1 | 0 | amphetamines | |
| etoperidone | [no description available] | medium | 1 | 0 | piperazines | |
| fenfluramine | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes;
secondary amino compound | appetite depressant;
serotonergic agonist;
serotonin uptake inhibitor |
| dihydroxyphenylalanine | [no description available] | medium | 1 | 0 | hydroxyphenylalanine;
non-proteinogenic alpha-amino acid;
tyrosine derivative | human metabolite |
| 1-(3-chlorophenyl)piperazine | [no description available] | medium | 1 | 0 | monochlorobenzenes;
N-arylpiperazine | drug metabolite;
environmental contaminant;
serotonergic agonist;
xenobiotic |
| salicylic acid | [no description available] | medium | 1 | 0 | monohydroxybenzoic acid | algal metabolite;
antifungal agent;
antiinfective agent;
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor;
keratolytic drug;
plant hormone;
plant metabolite |
| aspirin | [no description available] | medium | 1 | 0 | benzoic acids;
phenyl acetates;
salicylates | anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent |
| prednisone | [no description available] | medium | 1 | 0 | 11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone | adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
immunosuppressive agent;
prodrug |
| salicylates | [no description available] | medium | 1 | 0 | monohydroxybenzoate | plant metabolite |
| ent-dextilidine | [no description available] | medium | 1 | 0 | ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate | |
| rp 31264 | [no description available] | medium | 1 | 0 | | |
| sulfur | [no description available] | medium | 1 | 0 | chalcogen;
nonmetal atom | macronutrient |
| deoxyglucose | [no description available] | medium | 1 | 1 | | |
| fluorodeoxyglucose f18 | [no description available] | medium | 1 | 1 | 2-deoxy-2-((18)F)fluoro-D-glucose;
2-deoxy-2-fluoro-aldehydo-D-glucose | |
| thiothixene | [no description available] | medium | 1 | 0 | thioxanthenes | |
| methsuximide | [no description available] | medium | 1 | 0 | organic molecular entity | |
| 1-methyl-beta-carboline-3-carboxylic acid | [no description available] | medium | 1 | 0 | | |
| s,n,n'-tripropylthiocarbamate | [no description available] | medium | 1 | 0 | tertiary amine | |
| fomesafen | [no description available] | medium | 1 | 0 | aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-sulfonylcarboxamide;
organofluorine compound;
phenols | agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide |
| aminolevulinic acid | [no description available] | low | 0 | 0 | 4-oxo monocarboxylic acid;
amino acid zwitterion;
delta-amino acid | antineoplastic agent;
dermatologic drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite;
prodrug;
Saccharomyces cerevisiae metabolite |
| pyrazinamide | [no description available] | low | 0 | 0 | monocarboxylic acid amide;
N-acylammonia;
pyrazines | antitubercular agent;
prodrug |
| uracil | [no description available] | low | 0 | 0 | pyrimidine nucleobase;
pyrimidone | allergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prodrug;
Saccharomyces cerevisiae metabolite |
| acemetacin | [no description available] | low | 0 | 0 | carboxylic ester;
indol-3-yl carboxylic acid;
monocarboxylic acid;
monochlorobenzenes;
N-acylindole | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug |
| amifostine anhydrous | [no description available] | low | 0 | 0 | diamine;
organic thiophosphate | antioxidant;
prodrug;
radiation protective agent |
| amodiaquine | [no description available] | low | 0 | 0 | aminoquinoline;
organochlorine compound;
phenols;
secondary amino compound;
tertiary amino compound | anticoronaviral agent;
antimalarial;
drug allergen;
EC 2.1.1.8 (histamine N-methyltransferase) inhibitor;
non-steroidal anti-inflammatory drug;
prodrug |
| ampiroxicam | [no description available] | low | 0 | 0 | acetal;
aminopyridine;
benzothiazine;
etabonate ester;
monocarboxylic acid amide;
sulfonamide | analgesic;
antirheumatic drug;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug;
prodrug |
| azathioprine | [no description available] | low | 0 | 0 | aryl sulfide;
C-nitro compound;
imidazoles;
thiopurine | antimetabolite;
antineoplastic agent;
carcinogenic agent;
DNA synthesis inhibitor;
hepatotoxic agent;
immunosuppressive agent;
prodrug |
| chlorazepate | [no description available] | low | 0 | 0 | 1,4-benzodiazepinone | anticonvulsant;
anxiolytic drug;
GABA modulator;
prodrug |
| dacarbazine | [no description available] | low | 0 | 0 | imidazoles;
monocarboxylic acid amide;
triazene derivative | alkylating agent;
antineoplastic agent;
carcinogenic agent;
prodrug |
| dipivefrin | [no description available] | low | 0 | 0 | ethanolamines;
pivalate ester | adrenergic agonist;
antiglaucoma drug;
ophthalmology drug;
prodrug;
sympathomimetic agent |
| dipyrone | [no description available] | low | 0 | 0 | amino sulfonic acid;
pyrazoles | anti-inflammatory agent;
antipyretic;
antirheumatic drug;
cyclooxygenase 3 inhibitor;
non-narcotic analgesic;
peripheral nervous system drug;
prodrug |
| etanidazole | [no description available] | low | 0 | 0 | C-nitro compound;
imidazoles;
monocarboxylic acid amide | alkylating agent;
antineoplastic agent;
prodrug;
radiosensitizing agent |
| brl 42810 | [no description available] | low | 0 | 0 | 2-aminopurines;
acetate ester | antiviral drug;
prodrug |
| flucytosine | [no description available] | low | 0 | 0 | aminopyrimidine;
nucleoside analogue;
organofluorine compound;
pyrimidine antifungal drug;
pyrimidone | prodrug |
| fluphenazine depot | [no description available] | low | 0 | 0 | decanoate ester;
N-alkylpiperazine;
organofluorine compound;
phenothiazines | dopaminergic antagonist;
phenothiazine antipsychotic drug;
prodrug |
| leflunomide | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes;
isoxazoles;
monocarboxylic acid amide | antineoplastic agent;
antiparasitic agent;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
hepatotoxic agent;
immunosuppressive agent;
non-steroidal anti-inflammatory drug;
prodrug;
pyrimidine synthesis inhibitor;
tyrosine kinase inhibitor |
| loxoprofen | [no description available] | low | 0 | 0 | cyclopentanones;
monocarboxylic acid | antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug |
| metronidazole | [no description available] | low | 0 | 0 | C-nitro compound;
imidazoles;
primary alcohol | antiamoebic agent;
antibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
environmental contaminant;
prodrug;
radiosensitizing agent;
xenobiotic |
| midodrine | [no description available] | low | 0 | 0 | amino acid amide;
aromatic ether;
secondary alcohol | alpha-adrenergic agonist;
prodrug;
sympathomimetic agent;
vasoconstrictor agent |
| nabumetone | [no description available] | low | 0 | 0 | methoxynaphthalene;
methyl ketone | cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug |
| 4-phenylbutyric acid | [no description available] | low | 0 | 0 | monocarboxylic acid | antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor;
prodrug |
| proglumetacin | [no description available] | low | 0 | 0 | aromatic ether;
benzamides;
carboxylic ester;
monochlorobenzenes;
N-acylindole;
N-alkylpiperazine | antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
lipoxygenase inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug |
| salicylsalicylic acid | [no description available] | low | 0 | 0 | benzoate ester;
benzoic acids;
phenols;
salicylates | antineoplastic agent;
antirheumatic drug;
EC 3.5.2.6 (beta-lactamase) inhibitor;
hypoglycemic agent;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug |
| 4-phenylbutyric acid, sodium salt | [no description available] | low | 0 | 0 | organic sodium salt | EC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector;
neuroprotective agent;
orphan drug;
prodrug |
| suxibuzone | [no description available] | low | 0 | 0 | hemisuccinate;
monocarboxylic acid;
pyrazolidines | antirheumatic drug;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug;
prodrug |
| tazarotene | [no description available] | low | 0 | 0 | acetylenic compound;
ethyl ester;
pyridines;
retinoid;
thiochromane | keratolytic drug;
prodrug;
teratogenic agent |
| temozolomide | [no description available] | low | 0 | 0 | imidazotetrazine;
monocarboxylic acid amide;
triazene derivative | alkylating agent;
antineoplastic agent;
prodrug |
| tributyrin | [no description available] | low | 0 | 0 | butyrate ester;
triglyceride | antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor;
prodrug;
protective agent |
| mestranol | [no description available] | low | 0 | 0 | 17beta-hydroxy steroid;
aromatic ether;
terminal acetylenic compound | prodrug;
xenoestrogen |
| 1,4-butanediol | [no description available] | low | 0 | 0 | butanediol;
glycol | neurotoxin;
prodrug;
protic solvent |
| lucanthone | [no description available] | low | 0 | 0 | thioxanthenes | adjuvant;
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
mutagen;
photosensitizing agent;
prodrug;
schistosomicide drug |
| psilocybin | [no description available] | low | 0 | 0 | organic phosphate;
tertiary amino compound;
tryptamine alkaloid | fungal metabolite;
hallucinogen;
prodrug;
serotonergic agonist |
| azaribine | [no description available] | low | 0 | 0 | acetate ester;
N-glycosyl-1,2,4-triazine | antipsoriatic;
prodrug |
| doxifluridine | [no description available] | low | 0 | 0 | organofluorine compound;
pyrimidine 5'-deoxyribonucleoside | antimetabolite;
antineoplastic agent;
prodrug |
| diloxanide furoate | [no description available] | low | 0 | 0 | carboxylic ester;
furans;
organochlorine compound;
tertiary carboxamide | antiamoebic agent;
prodrug |
| pn 401 | [no description available] | low | 0 | 0 | acetate ester;
uridines | neuroprotective agent;
orphan drug;
prodrug |
| beclomethasone dipropionate | [no description available] | low | 0 | 0 | 11beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
corticosteroid;
enone;
glucocorticoid;
propanoate ester;
steroid ester | anti-arrhythmia drug;
anti-asthmatic drug;
anti-inflammatory drug;
prodrug |
| olsalazine | [no description available] | low | 0 | 0 | azobenzenes;
dicarboxylic acid | non-steroidal anti-inflammatory drug;
prodrug |
| ancitabine | [no description available] | low | 0 | 0 | diol;
organic heterotricyclic compound | antimetabolite;
antineoplastic agent;
prodrug |
| fludarabine phosphate | [no description available] | low | 0 | 0 | nucleoside analogue;
organofluorine compound;
purine arabinonucleoside monophosphate | antimetabolite;
antineoplastic agent;
antiviral agent;
DNA synthesis inhibitor;
immunosuppressive agent;
prodrug |
| carbimazole | [no description available] | low | 0 | 0 | 1,3-dihydroimidazole-2-thiones;
carbamate ester | antithyroid drug;
prodrug |
| pivampicillin | [no description available] | low | 0 | 0 | penicillanic acid ester;
pivaloyloxymethyl ester | prodrug |
| bitolterol | [no description available] | low | 0 | 0 | carboxylic ester;
diester;
ethanolamines;
secondary alcohol;
secondary amino compound | anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
prodrug |
| lovastatin | [no description available] | low | 0 | 0 | delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring) | anticholesteremic drug;
antineoplastic agent;
Aspergillus metabolite;
prodrug |
| simvastatin | [no description available] | low | 0 | 0 | delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
statin (semi-synthetic) | EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
ferroptosis inducer;
geroprotector;
prodrug |
| bambuterol hydrochloride | [no description available] | low | 0 | 0 | carbamate ester;
hydrochloride;
phenylethanolamines | anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
prodrug;
sympathomimetic agent |
| bambuterol | [no description available] | low | 0 | 0 | carbamate ester;
phenylethanolamines | anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
prodrug;
sympathomimetic agent;
tocolytic agent |
| quinapril | [no description available] | low | 0 | 0 | dicarboxylic acid monoester;
ethyl ester;
isoquinolines;
tertiary carboxamide | antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug |
| cilazapril, anhydrous | [no description available] | low | 0 | 0 | dicarboxylic acid monoester;
ethyl ester;
pyridazinodiazepine | antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug |
| gemcitabine | [no description available] | low | 0 | 0 | organofluorine compound;
pyrimidine 2'-deoxyribonucleoside | antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic |
| lamivudine | [no description available] | low | 0 | 0 | monothioacetal;
nucleoside analogue;
oxacycle;
primary alcohol | allergen;
anti-HBV agent;
antiviral drug;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor;
HIV-1 reverse transcriptase inhibitor;
prodrug |
| irinotecan | [no description available] | low | 0 | 0 | carbamate ester;
delta-lactone;
N-acylpiperidine;
pyranoindolizinoquinoline;
ring assembly;
tertiary alcohol;
tertiary amino compound | antineoplastic agent;
apoptosis inducer;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug |
| adefovir dipivoxil | [no description available] | low | 0 | 0 | 6-aminopurines;
carbonate ester;
ether;
organic phosphonate | antiviral drug;
DNA synthesis inhibitor;
HIV-1 reverse transcriptase inhibitor;
nephrotoxic agent;
prodrug |
| capecitabine | [no description available] | low | 0 | 0 | carbamate ester;
cytidines;
organofluorine compound | antimetabolite;
antineoplastic agent;
prodrug |
| baicalin | [no description available] | low | 0 | 0 | dihydroxyflavone;
glucosiduronic acid;
glycosyloxyflavone;
monosaccharide derivative | antiatherosclerotic agent;
antibacterial agent;
anticoronaviral agent;
antineoplastic agent;
antioxidant;
cardioprotective agent;
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
ferroptosis inhibitor;
neuroprotective agent;
non-steroidal anti-inflammatory drug;
plant metabolite;
prodrug |
| oseltamivir | [no description available] | low | 0 | 0 | acetamides;
amino acid ester;
cyclohexenecarboxylate ester;
primary amino compound | antiviral drug;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
environmental contaminant;
prodrug;
xenobiotic |
| lenampicillin | [no description available] | low | 0 | 0 | ketene acetal;
penicillanic acid ester | prodrug |
| droxicam | [no description available] | low | 0 | 0 | organic heterotricyclic compound;
pyridines | cyclooxygenase 1 inhibitor;
hepatotoxic agent;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor;
prodrug |
| talampicillin | [no description available] | low | 0 | 0 | penicillanic acid ester | prodrug |
| prednisolone phosphate | [no description available] | low | 0 | 0 | 11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
glucocorticoid;
steroid phosphate;
tertiary alpha-hydroxy ketone | anti-inflammatory agent;
antineoplastic agent;
glucocorticoid receptor agonist;
prodrug |
| irinotecan hydrochloride | [no description available] | low | 0 | 0 | hydrochloride | antineoplastic agent;
apoptosis inducer;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug |
| benzoylmetronidazole | [no description available] | low | 0 | 0 | benzoate ester | antibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
prodrug |
| zofenopril | [no description available] | low | 0 | 0 | aryl sulfide;
L-proline derivative;
N-acyl-L-amino acid;
thioester | anticonvulsant;
apoptosis inhibitor;
cardioprotective agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug;
vasodilator agent |
| droxidopa | [no description available] | low | 0 | 0 | catechols;
L-tyrosine derivative | antihypertensive agent;
prodrug;
vasoconstrictor agent |
| fingolimod hydrochloride | [no description available] | low | 0 | 0 | hydrochloride | immunosuppressive agent;
prodrug;
sphingosine-1-phosphate receptor agonist |
| fingolimod | [no description available] | low | 0 | 0 | aminodiol;
primary amino compound | antineoplastic agent;
CB1 receptor antagonist;
immunosuppressive agent;
prodrug;
sphingosine-1-phosphate receptor agonist |
| amdinocillin pivoxil | [no description available] | low | 0 | 0 | penicillanic acid ester;
penicillin;
pivaloyloxymethyl ester | antibacterial drug;
antiinfective agent;
prodrug |
| parecoxib | [no description available] | low | 0 | 0 | isoxazoles;
N-sulfonylcarboxamide | cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug |
| aminolevulinic acid hydrochloride | [no description available] | low | 0 | 0 | hydrochloride | antineoplastic agent;
dermatologic drug;
photosensitizing agent;
prodrug |
| cefotiam hexetil | [no description available] | low | 0 | 0 | carboxylic ester | prodrug |
| fosamprenavir | [no description available] | low | 0 | 0 | sulfonamide | prodrug |
| nepafenac | [no description available] | low | 0 | 0 | monocarboxylic acid amide | cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug |
| cyc 682 | [no description available] | low | 0 | 0 | nitrile;
nucleoside analogue;
secondary carboxamide | antimetabolite;
antineoplastic agent;
DNA synthesis inhibitor;
prodrug |
| methyl 5-aminolevulinate hydrochloride | [no description available] | low | 0 | 0 | hydrochloride | antineoplastic agent;
dermatologic drug;
photosensitizing agent;
prodrug |
| methyl 5-aminolevulinate | [no description available] | low | 0 | 0 | delta-amino acid ester | antineoplastic agent;
dermatologic drug;
photosensitizing agent;
prodrug |
| dabigatran etexilate | [no description available] | low | 0 | 0 | aromatic amide;
benzimidazoles;
beta-alanine derivative;
carboxamidine;
carboxylic ester;
pyridines | anticoagulant;
EC 3.4.21.5 (thrombin) inhibitor;
prodrug |
| fosfluconazole | [no description available] | low | 0 | 0 | conazole antifungal drug;
triazole antifungal drug;
triazoles | prodrug |
| 2-hydroxyestradiol | [no description available] | low | 0 | 0 | 17beta-hydroxy steroid;
2-hydroxy steroid | carcinogenic agent;
human metabolite;
metabolite;
mouse metabolite;
prodrug |
| salicin | [no description available] | low | 0 | 0 | aromatic primary alcohol;
aryl beta-D-glucoside;
benzyl alcohols | antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug |
| bacampicillin | [no description available] | low | 0 | 0 | penicillanic acid ester | prodrug |
| tiazofurin | [no description available] | low | 0 | 0 | 1,3-thiazoles;
C-glycosyl compound;
monocarboxylic acid amide | antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
prodrug |
| rubitecan | [no description available] | low | 0 | 0 | C-nitro compound;
delta-lactone;
pyranoindolizinoquinoline;
semisynthetic derivative;
tertiary alcohol | antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug |
| sulindac | [no description available] | low | 0 | 0 | monocarboxylic acid;
organofluorine compound;
sulfoxide | analgesic;
antineoplastic agent;
antipyretic;
apoptosis inducer;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug;
tocolytic agent |
| ethionamide | [no description available] | low | 0 | 0 | pyridines;
thiocarboxamide | antilipemic drug;
antitubercular agent;
fatty acid synthesis inhibitor;
leprostatic drug;
prodrug |
| nelarabine | [no description available] | low | 0 | 0 | beta-D-arabinoside;
monosaccharide derivative;
purine nucleoside | antineoplastic agent;
DNA synthesis inhibitor;
prodrug |
| amrubicin | [no description available] | low | 0 | 0 | anthracycline antibiotic;
methyl ketone;
primary amino compound;
quinone;
tetracenes | antineoplastic agent;
prodrug;
topoisomerase II inhibitor |
| mycophenolate mofetil | [no description available] | low | 0 | 0 | carboxylic ester;
ether;
gamma-lactone;
phenols;
tertiary amino compound | anticoronaviral agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
immunosuppressive agent;
prodrug |
| uf 021 | [no description available] | low | 0 | 0 | isopropyl ester;
ketone;
prostaglandins Falpha | antiglaucoma drug;
antihypertensive agent;
prodrug |
| travoprost | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes;
isopropyl ester;
prostaglandins Falpha | antiglaucoma drug;
antihypertensive agent;
ophthalmology drug;
prodrug;
prostaglandin receptor agonist |
| latanoprost | [no description available] | low | 0 | 0 | isopropyl ester;
prostaglandins Falpha;
triol | antiglaucoma drug;
antihypertensive agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor;
prodrug |
| spirapril | [no description available] | low | 0 | 0 | azaspiro compound;
dicarboxylic acid monoester;
dipeptide;
dithioketal;
ethyl ester;
pyrrolidinecarboxylic acid;
secondary amino compound;
tertiary carboxamide | antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug |
| dextromethorphan | [no description available] | low | 0 | 0 | 6-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthrene | antitussive;
environmental contaminant;
neurotoxin;
NMDA receptor antagonist;
oneirogen;
prodrug;
xenobiotic |
| benazepril | [no description available] | low | 0 | 0 | benzazepine;
dicarboxylic acid monoester;
ethyl ester;
lactam | EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug |
| ramipril | [no description available] | low | 0 | 0 | azabicycloalkane;
cyclopentapyrrole;
dicarboxylic acid monoester;
dipeptide;
ethyl ester | bradykinin receptor B2 agonist;
cardioprotective agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
matrix metalloproteinase inhibitor;
prodrug |
| enalapril maleate | [no description available] | low | 0 | 0 | maleate salt | antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug |
| enalapril | [no description available] | low | 0 | 0 | dicarboxylic acid monoester;
dipeptide | antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
geroprotector;
prodrug |
| heroin | [no description available] | low | 0 | 0 | morphinane alkaloid | mu-opioid receptor agonist;
opioid analgesic;
prodrug |
| imidapril | [no description available] | low | 0 | 0 | dicarboxylic acid monoester;
dipeptide;
ethyl ester;
imidazolidines;
N-acylurea;
secondary amino compound | antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug |
| ximelagatran | [no description available] | low | 0 | 0 | amidoxime;
azetidines;
carboxamide;
ethyl ester;
hydroxylamines;
secondary amino compound;
secondary carboxamide;
tertiary carboxamide | anticoagulant;
EC 3.4.21.5 (thrombin) inhibitor;
prodrug;
serine protease inhibitor |
| trandolapril | [no description available] | low | 0 | 0 | dicarboxylic acid monoester;
dipeptide;
ethyl ester;
organic heterobicyclic compound;
secondary amino compound;
tertiary carboxamide | antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug |
| tenofovir disoproxil fumarate | [no description available] | low | 0 | 0 | fumarate salt | antiviral drug;
HIV-1 reverse transcriptase inhibitor;
prodrug |
| cefditoren pivoxil | [no description available] | low | 0 | 0 | 1,3-thiazoles;
cephams;
oxime O-ether;
pivaloyloxymethyl ester | antibacterial drug;
prodrug |
| dirithromycin | [no description available] | low | 0 | 0 | macrolide antibiotic | prodrug |
| cefpodoxime proxetil | [no description available] | low | 0 | 0 | carboxylic acid;
carboxylic ester;
cephalosporin | antibacterial drug;
prodrug |
| gs-7340 | [no description available] | low | 0 | 0 | 6-aminopurines;
ether;
isopropyl ester;
L-alanine derivative;
phosphoramidate ester | antiviral drug;
HIV-1 reverse transcriptase inhibitor;
prodrug |
| abiraterone acetate | [no description available] | low | 0 | 0 | pyridines;
sterol ester | antineoplastic agent;
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor;
prodrug |
| ppi-0903 | [no description available] | low | 0 | 0 | 1,3-thiazoles;
cephalosporin;
iminium betaine;
organic phosphoramidate;
oxime O-ether;
thiadiazoles | antibacterial drug;
antimicrobial agent;
prodrug |
| fluticasone furoate | [no description available] | low | 0 | 0 | 11beta-hydroxy steroid;
2-furoate ester;
3-oxo-Delta(1),Delta(4)-steroid;
corticosteroid;
fluorinated steroid;
steroid ester;
thioester | anti-allergic agent;
anti-asthmatic drug;
prodrug |
| naproxen-n-butyl nitrate | [no description available] | low | 0 | 0 | carboxylic ester;
methoxynaphthalene;
nitrate ester | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
nitric oxide donor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug |
| varespladib methyl | [no description available] | low | 0 | 0 | aromatic ether;
benzenes;
indoles;
methyl ester;
primary carboxamide | anti-inflammatory drug;
antidote;
EC 3.1.1.4 (phospholipase A2) inhibitor;
prodrug |
| selexipag | [no description available] | low | 0 | 0 | aromatic amine;
ether;
monocarboxylic acid amide;
N-sulfonylcarboxamide;
pyrazines;
tertiary amino compound | orphan drug;
platelet aggregation inhibitor;
prodrug;
prostacyclin receptor agonist;
vasodilator agent |
| jte 607 | [no description available] | low | 0 | 0 | hydrochloride | anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
cardioprotective agent;
CPSF3 inhibitor;
prodrug |
| penamecillin | [no description available] | low | 0 | 0 | penicillanic acid ester;
semisynthetic derivative | antibacterial drug;
prodrug |
| etc-1002 | [no description available] | low | 0 | 0 | alpha,omega-dicarboxylic acid | antilipemic drug;
EC 2.3.3.8 (ATP citrate synthase) inhibitor;
prodrug |
| rx-3117 | [no description available] | low | 0 | 0 | organofluorine compound;
primary allylic alcohol;
triol | antimetabolite;
antineoplastic agent;
apoptosis inducer;
DNA synthesis inhibitor;
prodrug |
| tedizolid phosphate | [no description available] | low | 0 | 0 | carbamate ester;
organofluorine compound;
oxazolidinone;
phosphate monoester;
pyridines;
tetrazoles | antimicrobial agent;
prodrug;
protein synthesis inhibitor |
| azd 1152 | [no description available] | low | 0 | 0 | anilide;
monoalkyl phosphate;
monofluorobenzenes;
pyrazoles;
quinazolines;
secondary amino compound;
secondary carboxamide;
tertiary amino compound | antineoplastic agent;
Aurora kinase inhibitor;
prodrug |
| brl 15572 | [no description available] | low | 0 | 0 | hydrochloride | prodrug;
serotonergic antagonist |
| N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide | [no description available] | low | 0 | 0 | hydrobromide | dopamine agonist;
prodrug |
| sk&f 77434 | [no description available] | low | 0 | 0 | hydrobromide | dopamine agonist;
prodrug |
| methylprednisolone suleptanate | [no description available] | low | 0 | 0 | organic sodium salt | anti-asthmatic drug;
anti-inflammatory agent;
glucocorticoid receptor agonist;
prodrug |
| cefamandole nafate | [no description available] | low | 0 | 0 | organic sodium salt | antibacterial drug;
prodrug |
| sofosbuvir | [no description available] | low | 0 | 0 | isopropyl ester;
L-alanyl ester;
nucleotide conjugate;
organofluorine compound;
phosphoramidate ester | antiviral drug;
hepatitis C protease inhibitor;
prodrug |
| ML-210 | [no description available] | low | 0 | 0 | C-nitro compound;
diarylmethane;
isoxazoles;
monochlorobenzenes;
N-acylpiperazine;
N-alkylpiperazine;
tertiary carboxamide | antineoplastic agent;
EC 1.11.1.9 (glutathione peroxidase) inhibitor;
ferroptosis inducer;
prodrug |
| aripiprazole lauroxil | [no description available] | low | 0 | 0 | aromatic ether;
delta-lactam;
dichlorobenzene;
dodecanoate ester;
N-alkylpiperazine;
N-arylpiperazine;
quinolone | H1-receptor antagonist;
prodrug;
second generation antipsychotic;
serotonergic agonist |
| cgs 12066b | [no description available] | low | 0 | 0 | maleate salt | prodrug;
serotonergic agonist |
| s 8932 | [no description available] | low | 0 | 0 | aromatic amine;
C-nucleoside;
carboxylic ester;
nitrile;
phosphoramidate ester;
pyrrolotriazine | anticoronaviral agent;
antiviral drug;
prodrug |
| tak 491 | [no description available] | low | 0 | 0 | 1,2,4-oxadiazole;
aromatic ether;
benzimidazoles;
carboxylic ester;
cyclic carbonate ester;
dioxolane | angiotensin receptor antagonist;
antihypertensive agent;
prodrug |
| valganciclovir | [no description available] | low | 0 | 0 | L-valyl ester;
purines | antiviral drug;
prodrug |
| fosaprepitant | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes;
cyclic acetal;
morpholines;
phosphoramide;
triazoles | antiemetic;
neurokinin-1 receptor antagonist;
prodrug |
| molnupiravir | [no description available] | low | 0 | 0 | isopropyl ester;
ketoxime;
nucleoside analogue | anticoronaviral agent;
antiviral drug;
prodrug |
| PF-07304814 | [no description available] | low | 0 | 0 | aromatic ether;
indolecarboxamide;
L-leucine derivative;
phosphate monoester;
pyrrolidin-2-ones;
secondary carboxamide | anticoronaviral agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
prodrug |
| aminooxyacetic acid | [no description available] | low | 0 | 0 | amino acid;
hydroxylamines;
monocarboxylic acid | anticonvulsant;
EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor;
EC 4.2.1.22 (cystathionine beta-synthase) inhibitor;
nootropic agent |
| vanillin | [no description available] | low | 0 | 0 | benzaldehydes;
monomethoxybenzene;
phenols | anti-inflammatory agent;
anticonvulsant;
antioxidant;
flavouring agent;
plant metabolite |
| tramiprosate | [no description available] | low | 0 | 0 | amino sulfonic acid;
zwitterion | algal metabolite;
anti-inflammatory agent;
anticonvulsant;
GABA agonist;
nootropic agent |
| aminoglutethimide | [no description available] | low | 0 | 0 | dicarboximide;
piperidones;
substituted aniline | adrenergic agent;
anticonvulsant;
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor |
| estazolam | [no description available] | low | 0 | 0 | triazoles;
triazolobenzodiazepine | anticonvulsant;
anxiolytic drug;
GABA modulator |
| ethotoin | [no description available] | low | 0 | 0 | imidazolidine-2,4-dione | anticonvulsant |
| lamotrigine | [no description available] | low | 0 | 0 | 1,2,4-triazines;
dichlorobenzene;
primary arylamine | anticonvulsant;
antidepressant;
antimanic drug;
calcium channel blocker;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
excitatory amino acid antagonist;
geroprotector;
non-narcotic analgesic;
xenobiotic |
| meclofenamic acid | [no description available] | low | 0 | 0 | aminobenzoic acid;
organochlorine compound;
secondary amino compound | analgesic;
anticonvulsant;
antineoplastic agent;
antipyretic;
antirheumatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug |
| nimetazepam | [no description available] | low | 0 | 0 | 1,4-benzodiazepinone;
C-nitro compound | anticonvulsant;
antispasmodic drug;
GABA modulator;
sedative |
| palmidrol | [no description available] | low | 0 | 0 | endocannabinoid;
N-(long-chain-acyl)ethanolamine;
N-(saturated fatty acyl)ethanolamine | anti-inflammatory drug;
anticonvulsant;
antihypertensive agent;
neuroprotective agent |
| prilocaine | [no description available] | low | 0 | 0 | amino acid amide;
monocarboxylic acid amide | anticonvulsant;
local anaesthetic |
| propofol | [no description available] | low | 0 | 0 | phenols | anticonvulsant;
antiemetic;
intravenous anaesthetic;
radical scavenger;
sedative |
| troglitazone | [no description available] | low | 0 | 0 | chromanes;
thiazolidinone | anticoagulant;
anticonvulsant;
antineoplastic agent;
antioxidant;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
hypoglycemic agent;
platelet aggregation inhibitor;
vasodilator agent |
| vigabatrin | [no description available] | low | 0 | 0 | gamma-amino acid | anticonvulsant;
EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor |
| zaleplon | [no description available] | low | 0 | 0 | nitrile;
pyrazolopyrimidine | anticonvulsant;
anxiolytic drug;
central nervous system depressant;
sedative |
| zonisamide | [no description available] | low | 0 | 0 | 1,2-benzoxazoles;
sulfonamide | anticonvulsant;
antioxidant;
central nervous system drug;
protective agent;
T-type calcium channel blocker |
| androsterone | [no description available] | low | 0 | 0 | 17-oxo steroid;
3alpha-hydroxy steroid;
androstanoid;
C19-steroid | androgen;
anticonvulsant;
human blood serum metabolite;
human metabolite;
human urinary metabolite;
mouse metabolite;
pheromone |
| lysine | [no description available] | low | 0 | 0 | aspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid | algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite |
| mephobarbital | [no description available] | low | 0 | 0 | barbiturates | anticonvulsant |
| paramethadione | [no description available] | low | 0 | 0 | oxazolidinone | anticonvulsant |
| 6-methoxybenzoxazolinone | [no description available] | low | 0 | 0 | aromatic ether;
benzoxazole | antibacterial agent;
anticonvulsant;
antifungal agent;
muscle relaxant;
plant metabolite |
| tricaprylin | [no description available] | low | 0 | 0 | octanoate ester;
triglyceride | anticonvulsant;
plant metabolite |
| decan-4-olide | [no description available] | low | 0 | 0 | gamma-lactone;
tetrahydrofuranone | anticonvulsant;
flavouring agent;
food additive |
| magnesium sulfate | [no description available] | low | 0 | 0 | magnesium salt;
metal sulfate;
organic magnesium salt | anaesthetic;
analgesic;
anti-arrhythmia drug;
anticonvulsant;
calcium channel blocker;
cardiovascular drug;
fertilizer;
tocolytic agent |
| sodium selenate | [no description available] | low | 0 | 0 | inorganic sodium salt | anticonvulsant;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
fertilizer |
| didesethylflurazepam | [no description available] | low | 0 | 0 | 1,4-benzodiazepinone;
monofluorobenzenes;
organochlorine compound;
primary amino compound | anticonvulsant;
anxiolytic drug;
drug metabolite;
GABAA receptor agonist;
sedative |
| oxcarbazepine | [no description available] | low | 0 | 0 | cyclic ketone;
dibenzoazepine | anticonvulsant;
drug allergen |
| adinazolam | [no description available] | low | 0 | 0 | triazolobenzodiazepine | anticonvulsant;
antidepressant;
anxiolytic drug;
sedative |
| midazolam hydrochloride | [no description available] | low | 0 | 0 | hydrochloride;
imidazobenzodiazepine | anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative |
| mk 458 | [no description available] | low | 0 | 0 | hydrochloride | anticonvulsant;
antiparkinson drug;
dopamine agonist |
| naxagolide | [no description available] | low | 0 | 0 | organic heterotricyclic compound;
phenols;
tertiary amino compound | anticonvulsant;
antiparkinson drug;
dopamine agonist |
| tiagabine | [no description available] | low | 0 | 0 | beta-amino acid;
piperidinemonocarboxylic acid;
tertiary amino compound;
thiophenes | anticonvulsant;
GABA reuptake inhibitor |
| pyrrolidine dithiocarbamate | [no description available] | low | 0 | 0 | dithiocarbamic acids;
pyrrolidines | anticonvulsant;
antineoplastic agent;
geroprotector;
neuroprotective agent;
NF-kappaB inhibitor;
radical scavenger |
| glutaurine | [no description available] | low | 0 | 0 | dipeptide zwitterion;
dipeptide;
L-glutamine derivative;
sulfonic acid | anticonvulsant;
anxiolytic drug;
hormone;
human metabolite;
mammalian metabolite;
mouse metabolite |
| tiagabine hydrochloride | [no description available] | low | 0 | 0 | hydrochloride | anticonvulsant;
GABA reuptake inhibitor |
| palmitone | [no description available] | low | 0 | 0 | dialkyl ketone | anticonvulsant;
metabolite |
| paxilline | [no description available] | low | 0 | 0 | diterpene alkaloid;
enone;
organic heterohexacyclic compound;
terpenoid indole alkaloid;
tertiary alcohol | anticonvulsant;
Aspergillus metabolite;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor;
genotoxin;
geroprotector;
mycotoxin;
Penicillium metabolite;
potassium channel blocker |
| 10-hydroxycarbamazepine | [no description available] | low | 0 | 0 | carboxamide;
dibenzoazepine;
ureas | anticonvulsant;
drug allergen;
sodium channel blocker |
| ezogabine | [no description available] | low | 0 | 0 | carbamate ester;
organofluorine compound;
secondary amino compound;
substituted aniline | anticonvulsant;
potassium channel modulator |
| eslicarbazepine acetate | [no description available] | low | 0 | 0 | acetate ester;
carboxamide;
dibenzoazepine;
ureas | anticonvulsant;
drug allergen |
| dizocilpine | [no description available] | low | 0 | 0 | secondary amino compound;
tetracyclic antidepressant | anaesthetic;
anticonvulsant;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist |
| carnosine | [no description available] | low | 0 | 0 | amino acid zwitterion;
dipeptide | anticonvulsant;
antineoplastic agent;
antioxidant;
Daphnia magna metabolite;
geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent |
| solasodine | [no description available] | low | 0 | 0 | alkaloid antibiotic;
azaspiro compound;
hemiaminal ether;
oxaspiro compound;
sapogenin;
steroid alkaloid | anticonvulsant;
antifungal agent;
antiinfective agent;
antioxidant;
antipyretic;
antispermatogenic agent;
apoptosis inducer;
cardiotonic drug;
central nervous system depressant;
diuretic;
immunomodulator;
plant metabolite;
teratogenic agent |
| L-cycloserine | [no description available] | low | 0 | 0 | 4-amino-1,2-oxazolidin-3-one | anti-HIV agent;
anticonvulsant;
EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor |
| alpha-asarone | [no description available] | low | 0 | 0 | asarone | anticonvulsant;
GABA modulator |
| thiopental | [no description available] | low | 0 | 0 | barbiturates | anticonvulsant;
drug allergen;
environmental contaminant;
intravenous anaesthetic;
sedative;
xenobiotic |
| zofenoprilate | [no description available] | low | 0 | 0 | aryl sulfide;
L-proline derivative;
N-acyl-L-amino acid;
thiol | anticonvulsant;
apoptosis inhibitor;
cardioprotective agent;
drug metabolite;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
vasodilator agent |
| acacetin | [no description available] | low | 0 | 0 | dihydroxyflavone;
monomethoxyflavone | anticonvulsant;
plant metabolite |
| hispidulin | [no description available] | low | 0 | 0 | monomethoxyflavone;
trihydroxyflavone | anti-inflammatory agent;
anticonvulsant;
antineoplastic agent;
antioxidant;
apoptosis inducer;
plant metabolite |
| levetiracetam | [no description available] | low | 0 | 0 | pyrrolidin-2-ones | anticonvulsant;
environmental contaminant;
xenobiotic |
| pregabalin | [no description available] | low | 0 | 0 | gamma-amino acid | anticonvulsant;
calcium channel blocker |
| dizocilpine maleate | [no description available] | low | 0 | 0 | maleate salt;
tetracyclic antidepressant | anaesthetic;
anticonvulsant;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist |
| sdz eaa 494 | [no description available] | low | 0 | 0 | monocarboxylic acid;
olefinic compound;
phosphonic acids;
piperazinecarboxylic acid;
tertiary amino compound | anticonvulsant;
neuroprotective agent;
NMDA receptor antagonist |
| ro 25-6981 | [no description available] | low | 0 | 0 | benzenes;
phenols;
piperidines;
secondary alcohol;
tertiary amino compound | anticonvulsant;
antidepressant;
neuroprotective agent;
NMDA receptor antagonist |
| 3,3-diethyl-2-pyrrolidinone | [no description available] | low | 0 | 0 | pyrrolidin-2-ones | anticonvulsant;
geroprotector |
| ucb 34714 | [no description available] | low | 0 | 0 | gamma-lactam;
non-proteinogenic amino acid derivative | anticonvulsant |
| perampanel | [no description available] | low | 0 | 0 | bipyridines;
nitrile;
pyridone | AMPA receptor antagonist;
anticonvulsant |
| arachidonoylserotonin | [no description available] | low | 0 | 0 | N-acylserotonin;
phenols | anti-inflammatory agent;
anticonvulsant;
antioxidant;
capsaicin receptor antagonist;
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor;
human metabolite;
signalling molecule |
| meclofenamate sodium anhydrous | [no description available] | low | 0 | 0 | hydrate | analgesic;
anticonvulsant;
antineoplastic agent;
antipyretic;
antirheumatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug |
| chlormezanone | [no description available] | low | 0 | 0 | 1,3-thiazine;
lactam;
monochlorobenzenes;
sulfone | antipsychotic agent;
anxiolytic drug;
muscle relaxant |
| etazolate | [no description available] | low | 0 | 0 | ethyl ester;
hydrazone;
pyrazolopyridine | alpha-secretase activator;
antidepressant;
antipsychotic agent;
anxiolytic drug;
GABA agent;
neuroprotective agent;
phosphodiesterase IV inhibitor |
| fludiazepam | [no description available] | low | 0 | 0 | 1,4-benzodiazepinone;
organochlorine compound;
organofluorine compound | anxiolytic drug |
| hydroxyzine | [no description available] | low | 0 | 0 | hydroxyether;
monochlorobenzenes;
N-alkylpiperazine | anticoronaviral agent;
antipruritic drug;
anxiolytic drug;
dermatologic drug;
H1-receptor antagonist |
| mirtazapine | [no description available] | low | 0 | 0 | benzazepine;
tetracyclic antidepressant | alpha-adrenergic antagonist;
anxiolytic drug;
H1-receptor antagonist;
histamine antagonist;
oneirogen;
serotonergic antagonist |
| ritanserin | [no description available] | low | 0 | 0 | organofluorine compound;
piperidines;
thiazolopyrimidine | antidepressant;
antipsychotic agent;
anxiolytic drug;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
serotonergic antagonist |
| buspirone hydrochloride | [no description available] | low | 0 | 0 | hydrochloride | anxiolytic drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
sedative;
serotonergic agonist |
| paroxetine hydrochloride | [no description available] | low | 0 | 0 | hydrochloride | antidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor |
| amperozide | [no description available] | low | 0 | 0 | diarylmethane;
monofluorobenzenes;
N-alkylpiperazine;
secondary carboxamide;
ureas | anxiolytic drug;
dopamine uptake inhibitor;
geroprotector;
second generation antipsychotic;
serotonergic antagonist |
| amperozide hydrochloride | [no description available] | low | 0 | 0 | hydrochloride | anxiolytic drug;
dopamine uptake inhibitor;
geroprotector;
second generation antipsychotic;
serotonergic antagonist |
| nicotine | [no description available] | low | 0 | 0 | 3-(1-methylpyrrolidin-2-yl)pyridine | anxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic |
| tandospirone | [no description available] | low | 0 | 0 | bridged compound;
dicarboximide;
N-alkylpiperazine;
N-arylpiperazine;
pyrimidines | antidepressant;
anxiolytic drug |
| 1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride | [no description available] | low | 0 | 0 | hydrochloride | anxiolytic drug;
serotonergic agonist |
| spinosin | [no description available] | low | 0 | 0 | dihydroxyflavone;
flavone C-glycoside;
monomethoxyflavone | anxiolytic drug;
plant metabolite |
| ANA-12 | [no description available] | low | 0 | 0 | 1-benzothiophenes;
caprolactams;
secondary carboxamide | antidepressant;
anxiolytic drug;
tropomyosin-related kinase B receptor antagonist |
| 6-methyl-2-(phenylethynyl)pyridine | [no description available] | low | 0 | 0 | acetylenic compound;
methylpyridines | anxiolytic drug;
metabotropic glutamate receptor antagonist |
| clavulanic acid | [no description available] | low | 0 | 0 | oxapenam | antibacterial drug;
anxiolytic drug;
bacterial metabolite;
EC 3.5.2.6 (beta-lactamase) inhibitor |
| paroxetine maleate | [no description available] | low | 0 | 0 | maleate salt | antidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor |
| 2-methyl-6-(phenylethynyl)pyridine hydrochloride | [no description available] | low | 0 | 0 | hydrochloride | anxiolytic drug;
metabotropic glutamate receptor antagonist |
| ly 404039 | [no description available] | low | 0 | 0 | bridged compound;
dicarboxylic acid;
non-proteinogenic amino acid derivative;
organic heterobicyclic compound;
sulfone | antipsychotic agent;
anxiolytic drug;
dopamine agonist;
metabotropic glutamate receptor agonist |
| vortioxetine | [no description available] | low | 0 | 0 | aryl sulfide;
N-arylpiperazine | antidepressant;
anxiolytic drug;
serotonergic agonist;
serotonergic antagonist |
| ly 379268 | [no description available] | low | 0 | 0 | amino dicarboxylic acid;
bridged compound;
organic heterobicyclic compound | antipsychotic agent;
anxiolytic drug;
metabotropic glutamate receptor agonist;
neuroprotective agent |
| demethylmirtazapine | [no description available] | low | 0 | 0 | benzazepine;
tetracyclic antidepressant | alpha-adrenergic antagonist;
anxiolytic drug;
H1-receptor antagonist;
histamine antagonist;
human xenobiotic metabolite;
serotonergic antagonist |
| secobarbital | [no description available] | low | 0 | 0 | barbiturates | anaesthesia adjuvant;
GABA modulator;
sedative |
| brexanolone | [no description available] | low | 0 | 0 | 3-hydroxy-5alpha-pregnan-20-one | antidepressant;
GABA modulator;
human metabolite;
intravenous anaesthetic;
sedative |
| 6,6-dimethyl-2-methylenebicyclo(3.1.1)heptan-3-ol | [no description available] | low | 0 | 0 | carbobicyclic compound;
pinane monoterpenoid;
secondary alcohol | GABA modulator;
mouse metabolite;
plant metabolite;
volatile oil component |
| isoliquiritigenin | [no description available] | low | 0 | 0 | chalcones | antineoplastic agent;
biological pigment;
EC 1.14.18.1 (tyrosinase) inhibitor;
GABA modulator;
geroprotector;
metabolite;
NMDA receptor antagonist |
| beta-asarone | [no description available] | low | 0 | 0 | asarone | GABA modulator |
| valerenic acid | [no description available] | low | 0 | 0 | carbobicyclic compound;
monocarboxylic acid;
sesquiterpenoid | GABA modulator;
plant metabolite;
sedative;
volatile oil component |
| verruculogen | [no description available] | low | 0 | 0 | aromatic ether;
diol;
indole alkaloid;
organic heterohexacyclic compound;
organic peroxide | Aspergillus metabolite;
GABA modulator;
mycotoxin;
Penicillium metabolite;
potassium channel blocker |
| potassium chloride | [no description available] | low | 0 | 0 | inorganic chloride;
inorganic potassium salt;
potassium salt | fertilizer |
| potassium iodide | [no description available] | low | 0 | 0 | potassium salt | expectorant;
radical scavenger |
| potassium cyanide | [no description available] | low | 0 | 0 | cyanide salt;
one-carbon compound;
potassium salt | EC 1.15.1.1 (superoxide dismutase) inhibitor;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
neurotoxin |
| potassium carbonate | [no description available] | low | 0 | 0 | carbonate salt;
potassium salt | catalyst;
fertilizer;
flame retardant |
| potassium citrate | [no description available] | low | 0 | 0 | potassium salt | diuretic |
| potassium nitrate | [no description available] | low | 0 | 0 | inorganic nitrate salt;
potassium salt | fertilizer |
| potassium dichromate | [no description available] | low | 0 | 0 | potassium salt | allergen;
oxidising agent;
sensitiser |
| potassium sulfate | [no description available] | low | 0 | 0 | inorganic potassium salt;
potassium salt | |
| potassium chromate(vi) | [no description available] | low | 0 | 0 | potassium salt | carcinogenic agent;
oxidising agent |
| potassium bromide | [no description available] | low | 0 | 0 | potassium salt | |
| potassium thiocyanate | [no description available] | low | 0 | 0 | potassium salt | |
| potassium bicarbonate | [no description available] | low | 0 | 0 | organic salt;
potassium salt | antifungal agrochemical;
buffer;
food acidity regulator;
raising agent |
| potassium acetate | [no description available] | low | 0 | 0 | potassium salt | food acidity regulator |
| potassium fluoride | [no description available] | low | 0 | 0 | fluoride salt;
potassium salt | NMR chemical shift reference compound;
poison |
| fremy's salt | [no description available] | low | 0 | 0 | aminoxyls;
potassium salt | |
| potassium oxide | [no description available] | low | 0 | 0 | metal oxide;
potassium salt | |
| clavulanate potassium | [no description available] | low | 0 | 0 | potassium salt | antibacterial drug;
antimicrobial agent;
EC 3.5.2.6 (beta-lactamase) inhibitor |
| potassium bromate | [no description available] | low | 0 | 0 | bromate salt;
potassium salt | flour treatment agent |